The addition of exogenous sIL-6R did not further promote the invasion of ovarian cancer cells induced by IL-6, suggesting that IL-6Rs (IL-6R and sIL-6R) produced from cancer cells are enough to activate IL-6/IL-6R signaling. The gene discussed is IL6; the disease is ovarian cancer.